600222.SH上海证券交易所 · 主板 Main
Taloph 太龙药业
Traditional Chinese Medicine 中药Ⅱ
¥8.03¥0.00 · +0.00%
Open 开盘
¥7.96
High 最高
¥8.16
Low 最低
¥7.93
Prev Close 昨收
¥8.03
Volume 成交量
1,402.2万股
Turnover 成交额
¥1.13亿
Mkt Cap 总市值
¥45亿
P/E 市盈率
85.3×
Recent Activity 近期动态All Filings 全部公告 →
8 significant filings since 30 May 2026: 2 on shares frozen, 2 on legal representative change and 1 on new listing, and 3 other kinds. The latest, on 10 Sep 2026: 太龙药业关于持股5%以上股东股份被轮候冻结的公告.
自 30 May 2026 起有 8 份重大公告：shares frozen 2 份、legal representative change 2 份、new listing 1 份，另有 3 类。最新一份（10 Sep 2026）：太龙药业关于持股5%以上股东股份被轮候冻结的公告。
2.505.007.5010.0012.5015.00
Volume 成交量
1.71亿
19992006201320202026
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Traditional Chinese Medicine 中药Ⅱ · 66 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥45亿 | ¥61亿 | 24th lowest of 66 · 66 家中第 24 低 | |
| Trailing P/E 市盈率 | 85.3x | 31.3x | 12th highest of 49 · 49 家中第 12 高 | |
| P/B 市净率 | 2.9x | 2.2x | 19th highest of 65 · 65 家中第 19 高 | |
| Revenue Growth 营收增速 | -3.2% | -7.4% | 26th highest of 66 · 66 家中第 26 高 | |
| Profit Growth 净利增速 | -37.8% | -0.2% | 17th lowest of 66 · 66 家中第 17 低 | |
| Gross Margin 毛利率 | 23.6% | 56.9% | 6th lowest of 66 · 66 家中第 6 低 | |
| Net Margin 净利率 | 1.8% | 9.6% | 19th lowest of 66 · 66 家中第 19 低 | |
| Return on Equity 净资产收益率 | 0.8% | 3.0% | 16th lowest of 65 · 65 家中第 16 低 | |
| Debt to Assets 资产负债率 | 54.0% | 28.4% | 6th highest of 66 · 66 家中第 6 高 | |
| Grade Score 评级得分 | 23 | 52 | 5th lowest of 66 · 66 家中第 5 低 |
Statement figures are for the period to 30 Jun 2026, filed by 66 of 66 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，66 家同业中 66 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Yunnan Baiyao Group 云南白药 | ¥890亿 | 17.0x | 2.2x | 2.9% | 16.9% | 9.0% | C |
| Zhangzhou Pientzehuang Pharmaceutical 片仔癀 | ¥708亿 | 39.1x | 4.8x | -15.0% | 23.7% | 7.3% | C |
| China Resources Sanjiu Medical 华润三九 | ¥389亿 | 11.9x | 1.7x | 1.4% | 13.3% | 7.3% | C |
| Beijing Tong Ren Tang 同仁堂 | ¥320亿 | 33.0x | 2.3x | -14.2% | 11.2% | 5.2% | D |
| Guangzhou Baiyunshan Pharmaceutical Holdings 白云山 | ¥315亿 | 12.3x | 0.8x | 0.6% | 5.1% | 5.4% | D |
| Dong-E-E-Jiao 东阿阿胶 | ¥289亿 | 16.2x | 2.8x | 3.4% | 27.3% | 8.1% | C |
| Tianjin Pharmaceutical Da Ren Tang 达仁堂 | ¥271亿 | 31.9x | 4.6x | -7.4% | 26.2% | 9.1% | C |
| Shijiazhuang Yiling Pharmaceutical 以岭药业 | ¥253亿 | 18.4x | 2.3x | 0.9% | 18.6% | 6.7% | B |
| Jumpcan 济川药业 | ¥225亿 | 12.2x | 1.6x | -15.3% | 33.6% | 5.3% | C |
| Jilin Aodong Pharmaceutical Group 吉林敖东 | ¥209亿 | 6.6x | 0.7x | -8.5% | 198.7% | 6.5% | C |
| Tasly 天士力 | ¥204亿 | 16.7x | 1.6x | -2.0% | 21.1% | 7.0% | C |
| Guangdong Zhongsheng Pharmaceutical 众生药业 | ¥198亿 | 99.6x | 5.0x | -23.0% | 10.7% | 2.7% | C |
| Kangmei Pharmaceutical 康美药业 | ¥184亿 | 624.3x | 2.5x | -11.1% | 1.6% | 0.5% | D |
| Buchang Pharma 步长制药 | ¥153亿 | 65.0x | 1.5x | -11.7% | 9.2% | 4.9% | D |
| Taloph 太龙药业 | ¥45亿 | 85.3x | 2.9x | -3.2% | 1.8% | 0.8% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。